Regenxbio Inc
NASDAQ:RGNX
Wall Street
Price Targets
RGNX Price Targets Summary
Regenxbio Inc
According to Wall Street analysts, the average 1-year price target for
RGNX
is 40.63 USD
with a low forecast of 21.21 USD and a high forecast of 57.75 USD.
RGNX Last Price Targets
Regenxbio Inc
The latest public price target was made on Mar 11, 2024 by
Yi Chen
from
H.C. Wainwright
,
who expects
RGNX
stock to
rise by 121%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Yi Chen
H.C. Wainwright
|
36
USD
Upside 121% |
1 month ago
Mar 11, 2024
|
H.C. Wainwright Starts Regenxbio Inc. (RGNX) at Buy; 'Advancing Gene Therapies in Ophthalmology and Rare Diseases'
StreetInsider
|
Luca Issi
RBC Capital
|
35
USD
Upside 115% |
1 month ago
Mar 8, 2024
|
RBC Capital Upgrades Regenxbio Inc. (RGNX) to Outperform
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RGNX's stock price target?
Price Target
40.63
USD
According to Wall Street analysts, the average 1-year price target for
RGNX
is 40.63 USD
with a low forecast of 21.21 USD and a high forecast of 57.75 USD.
What is Regenxbio Inc's Revenue forecast?
Projected CAGR
50%
For the last 8 years the
compound annual growth rate for
Regenxbio Inc's revenue is
36%.
The projected
CAGR
for the next 3 years is
50%.
You don't have any saved screeners yet
